Coral Laboratories Appoints Mr. Diwakar Unnikrishna Menon as Company Secretary and Compliance Officer

1 min read     Updated on 23 Apr 2026, 02:35 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Coral Laboratories Limited has appointed Mr. Diwakar Unnikrishna Menon (ACS: 8791) as Company Secretary and Compliance Officer effective April 30, 2026. The appointment was approved by the Board of Directors on April 23, 2026, based on the Nomination and Remuneration Committee's recommendation. Mr. Menon brings over 33 years of experience in compliance, legal, and industrial safety, having worked with reputed organizations like Godrej group and L&T group. The company confirmed he is not debarred by any regulatory authority and is not related to any directors, key managerial personnel, or promoters.

powered bylight_fuzz_icon
38480745

*this image is generated using AI for illustrative purposes only.

Coral Laboratories Limited has announced the appointment of Mr. Diwakar Unnikrishna Menon as Company Secretary and Compliance Officer, marking a significant addition to the company's leadership team. The appointment was formally approved by the Board of Directors during their meeting held on April 23, 2026.

Board Meeting Details

The Board of Directors convened at the company's registered office located at 3B, Patanwala Compound, Opp. Shreyas Cinema, L.B.S. Marg, Ghatkopar (W), Mumbai- 400086. The meeting commenced at 11:48 a.m. and concluded by 12:05 a.m. on the same day. The appointment was made based on the recommendation of the Nomination and Remuneration Committee.

Appointment Particulars

Parameter: Details
Name: Mr. Diwakar Unnikrishna Menon (ACS: 8791)
Designation: Company Secretary and Compliance Officer
Effective Date: April 30, 2026
Reason for Change: Appointment
Relationship Status: Not related to any directors, KMP, or promoters

Professional Background

Mr. Menon brings substantial expertise to his new role, with qualifications including Company Secretary certification, degrees in Commerce and Law, and a Master of Labour Studies. His extensive professional background spans over 33 years in the field of compliance, legal, and industrial safety and environment.

During his career tenure, Mr. Menon has worked with several reputed organizations, including the Godrej group and L&T group, providing him with comprehensive experience in corporate governance and regulatory compliance.

Regulatory Compliance

The company has confirmed that Mr. Menon is not debarred from holding office by virtue of any SEBI Order or any other regulatory authority. This appointment aligns with the requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure was made in the prescribed format under Regulation 30 read with Schedule III of the SEBI Listing Regulations and SEBI Master Circular dated January 30, 2026. The announcement was signed by Sushma Kadkade, Director & CFO (DIN: 07791735), on behalf of Coral Laboratories Limited.

Historical Stock Returns for Coral Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.92%+1.43%+7.25%-12.80%-38.29%+15.15%

What strategic initiatives might Coral Laboratories pursue under enhanced compliance leadership given Mr. Menon's extensive regulatory experience?

Could this senior appointment signal Coral Laboratories' preparation for potential expansion or new regulatory requirements in the pharmaceutical sector?

How might Mr. Menon's background with major conglomerates like Godrej and L&T influence Coral Laboratories' corporate governance practices going forward?

Coral Laboratories Submits SEBI Compliance Certificate for Quarter Ended March 31, 2026

1 min read     Updated on 15 Apr 2026, 12:35 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Coral Laboratories Limited filed its quarterly SEBI compliance certificate for Q4 FY26 with BSE Limited on April 15, 2026. The certificate under Regulation 74(5) was provided by registrar MUFG Intime India Private Limited, confirming proper dematerialisation processes and adherence to prescribed timelines for securities handling during the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37782355

*this image is generated using AI for illustrative purposes only.

Coral Laboratories Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate pertains to the quarter ended March 31, 2026, and was filed on April 15, 2026.

Regulatory Compliance Filing

The company submitted the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 to BSE Limited. The filing was made by Sushma Kadkade, Director & CFO (DIN: 07791735), from the company's Mumbai office.

Filing Details: Information
Quarter Ended: March 31, 2026
Filing Date: April 15, 2026
Exchange: BSE Limited
Scrip Code: 524506
Filed By: Sushma Kadkade, Director & CFO

Registrar Confirmation

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the company's registrar and share transfer agent. The firm provided the compliance certificate dated April 3, 2026, confirming adherence to dematerialisation regulations.

The registrar confirmed that securities received from depository participants for dematerialisation during the quarter ended March 31, 2026 were properly processed. All securities comprised in the certificates have been listed on stock exchanges where the company's earlier issued securities are traded.

Dematerialisation Process Compliance

The certificate confirms several key compliance aspects:

  • Securities received for dematerialisation were confirmed or rejected to depositories within prescribed timelines
  • Security certificates received were mutilated and cancelled after due verification by depository participants
  • Names of depositories were substituted in the register of members as registered owners
  • All processes followed prescribed regulatory timelines

Corporate Information

MUFG Intime India Private Limited operates from its registered address at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083. The certificate was signed by Ashok Shetty, Sr. Vice President-Corporate Registry, representing the registrar firm.

This quarterly filing demonstrates Coral Laboratories' commitment to maintaining regulatory compliance and ensuring proper dematerialisation processes for its securities trading on Indian stock exchanges.

Historical Stock Returns for Coral Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.92%+1.43%+7.25%-12.80%-38.29%+15.15%

What strategic initiatives might Coral Laboratories announce in their upcoming annual report for FY2026?

How could potential changes to SEBI's dematerialization regulations impact Coral Laboratories' compliance costs in future quarters?

Will Coral Laboratories consider expanding its listing to additional stock exchanges beyond BSE in the coming fiscal year?

More News on Coral Laboratories

1 Year Returns:-38.29%